Altimmune (ALT) - Management Comments

Altimmune (ALT) – Management Comments

Mar 15, 2021 07:05 AM Altimmune (ALT) Announces AdCOVID Single Dose, Intranasal COVID-19 Vaccine Candidate, Prevents SARS-CoV-2-induced Disease and Blocks Viral Replication in Preclinical Studies of SARS-CoV-2 Infection
Dec 30, 2020 08:02 AM Altimmune (ALT) Initiates Multinational Phase 2 Clinical Trial of HepTcellTM
Dec 23, 2020 04:03 PM
Dec 8, 2020 08:06 AM
Nov 25, 2020 07:02 AM
Aug 25, 2020 07:08 AM
Aug 7, 2020 07:23 AM
Jul 22, 2020 07:31 AM
Jun 30, 2020 07:04 AM
Jun 29, 2020 07:10 AM
Jun 22, 2020 07:06 AM
Mar 30, 2020 07:07 AM
Jan 23, 2020 07:06 AM
Sep 9, 2019 07:10 AM
Aug 21, 2019 07:09 AM
Jul 9, 2019 07:02 AM
Jun 12, 2019 08:07 AM
Jun 10, 2019 08:37 AM
Jun 5, 2019 08:05 AM
Mar 19, 2019 07:09 AM
Nov 27, 2018 09:11 AM
Sep 4, 2018 08:13 AM
Aug 31, 2018 08:01 AM
Jul 10, 2018 08:03 AM
Mar 27, 2018 08:05 AM
Jan 3, 2018 08:08 AM
Dec 11, 2017 08:09 AM
Aug 21, 2017 08:07 AM